CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 56(Granted Patents)

Company Filing History:

Ge Healthcare Dharmacon, Inc.

where one patent can have more than one assignee

Years Active: 2012-2016

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9334495 - Minor groove binder (MGB)-oligonucleotide miRNA antagonists (2016-05-10),

2. 8980855 - Minor groove binder (MGB)-oligonucleotide miRNA antagonists (2015-03-17),

3. 8809514 - Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference (2014-08-19),

4. 8501706 - Duplex oligonucleotide complexes and methods for gene silencing by RNA interference (2013-08-06),

5. 8252755 - Duplex oligonucleotide complexes and methods for gene silencing by RNA interference (2012-08-28),

Title: Rob Kaiser: Innovator in RNA Therapeutics

Introduction

Rob Kaiser is a notable inventor based in Broomfield, Colorado. He has made significant contributions to the field of RNA therapeutics, holding a total of five patents. His work focuses on innovative methods to inhibit the actions of non-coding RNAs, which play crucial roles in various biological processes.

Latest Patents

Kaiser’s latest patents include compositions and methods for inhibiting the actions of non-coding RNAs such as miRNAs and piRNAs. These compositions comprise single or double-stranded oligonucleotides conjugated with Minor Groove Binders (MGBs). The oligonucleotides can vary in length and may contain nucleotides with one or more modifications. They also have regions that are substantially complementary to one or more mature miRNAs or piRNAs.

Career Highlights

Throughout his career, Rob Kaiser has worked with prominent companies in the biotechnology sector, including Dharmacon, Inc. and GE Healthcare. His expertise in RNA technology has positioned him as a key player in the development of innovative therapeutic solutions.

Collaborations

Kaiser has collaborated with notable colleagues in the field, including Anastasia Khvorova and Christina Yamada. These partnerships have further enhanced his research and development efforts in RNA therapeutics.

Conclusion

Rob Kaiser is a distinguished inventor whose work in RNA therapeutics has led to significant advancements in the field. His innovative patents and collaborations reflect his commitment to improving therapeutic strategies for non-coding RNAs.

This text is generated by artificial intelligence and may not be accurate.